Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease.

Nuij VJAA, Peppelenbosch MP, van der Woude CJ, Fuhler GM.

J Transl Med. 2017 Dec 11;15(1):248. doi: 10.1186/s12967-017-1355-9.

2.

Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.

Eppinga H, Poortinga S, Thio HB, Nijsten TEC, Nuij VJAA, van der Woude CJ, Vodegel RM, Fuhler GM, Peppelenbosch MP.

Inflamm Bowel Dis. 2017 Oct;23(10):1783-1789. doi: 10.1097/MIB.0000000000001169.

PMID:
28617755
3.

The ATG16L1 risk allele associated with Crohn's disease results in a Rac1-dependent defect in dendritic cell migration that is corrected by thiopurines.

Wildenberg ME, Koelink PJ, Diederen K, Te Velde AA, Wolfkamp SC, Nuij VJ, Peppelenbosch MP, Nobis M, Sansom OJ, Anderson KI, van der Woude CJ, D'Haens GR, van den Brink GR.

Mucosal Immunol. 2017 Mar;10(2):352-360. doi: 10.1038/mi.2016.65. Epub 2016 Jul 20.

PMID:
27435106
4.

Disappointing durable remission rates in complex Crohn's disease fistula.

Molendijk I, Nuij VJ, van der Meulen-de Jong AE, van der Woude CJ.

Inflamm Bowel Dis. 2014 Nov;20(11):2022-8. doi: 10.1097/MIB.0000000000000148.

PMID:
25159455
5.

Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.

Parikh K, Zhou L, Somasundaram R, Fuhler GM, Deuring JJ, Blokzijl T, Regeling A, Kuipers EJ, Weersma RK, Nuij VJ, Alves M, Vogelaar L, Visser L, de Haar C, Krishnadath KK, van der Woude CJ, Dijkstra G, Faber KN, Peppelenbosch MP.

Sci Transl Med. 2014 Apr 23;6(233):233ra53. doi: 10.1126/scitranslmed.3006763.

6.

Peripheral neutrophil functions and cell signalling in Crohn`s disease.

Somasundaram R, Nuij VJ, van der Woude CJ, Kuipers EJ, Peppelenbosch MP, Fuhler GM.

PLoS One. 2013 Dec 19;8(12):e84521. doi: 10.1371/journal.pone.0084521. eCollection 2013.

7.

Phenotype of inflammatory bowel disease at diagnosis in the Netherlands: a population-based inception cohort study (the Delta Cohort).

Nuij VJ, Zelinkova Z, Rijk MC, Beukers R, Ouwendijk RJ, Quispel R, van Tilburg AJ, Tang TJ, Smalbraak H, Bruin KF, Lindenburg F, Peyrin-Biroulet L, van der Woude CJ; Dutch Delta IBD Group.

Inflamm Bowel Dis. 2013 Sep;19(10):2215-22. doi: 10.1097/MIB.0b013e3182961626.

PMID:
23835444
8.

Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.

Li Y, Nuij VJ, Baars JE, Biermann K, Kuipers EJ, Peppelenbosch MP, de Haar C, Janneke van der Woude C.

Inflamm Bowel Dis. 2013 Jan;19(1):132-40. doi: 10.1002/ibd.22992.

PMID:
22535619
9.

Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation.

Baars JE, Nuij VJ, Oldenburg B, Kuipers EJ, van der Woude CJ.

Inflamm Bowel Dis. 2012 Sep;18(9):1634-40. doi: 10.1002/ibd.21925. Epub 2011 Nov 8.

PMID:
22069022

Supplemental Content

Support Center